aspirin and ferrous sulfate

aspirin has been researched along with ferrous sulfate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bailey, RT; Bonavina, L; Brewer, AR; Demeester, TR; Eypasch, EP; Smyrk, TC1
Boldyrev, AA; Chasovnikova, LV; Formazyuk, VE; Sergienko, VI; Severin, SE1
Gerrard, JM; Peterson, DA; Rao, GH; White, JG1
Ashidate, K; Hirata, Y; Kawamura, M; Mimura, D; Miyazaki, S; Teramoto, T; Tohda, H; Yamamoto, Y1

Other Studies

4 other study(ies) available for aspirin and ferrous sulfate

ArticleYear
Drug-induced esophageal injury. Histopathological study in a rabbit model.
    Digestive diseases and sciences, 1990, Volume: 35, Issue:10

    Topics: Animals; Ascorbic Acid; Aspirin; Delayed-Action Preparations; Doxycycline; Esophagus; Ferrous Compounds; Ibuprofen; Potassium Chloride; Rabbits

1990
The antioxidative properties of carnosine and other drugs.
    Biochemistry international, 1990, Volume: 20, Issue:6

    Topics: Acridines; alpha-Tocopherol; Animals; Aspirin; Carnosine; Cataract; Dipeptides; Ferrous Compounds; Kinetics; Lipid Peroxidation; Oxazines; Oxidation-Reduction; Rats; Thiobarbiturates; Tocopherols; Vitamin E

1990
Salicylic acid inhibition of the irreversible effect of acetylsalicyclic aicd on prostaglandin synthetase may be due to competition for the enzyme cationic binding site.
    Prostaglandins and medicine, 1981, Volume: 6, Issue:2

    Topics: Arachidonic Acids; Aspirin; Binding, Competitive; Chemical Phenomena; Chemistry; Cyclooxygenase Inhibitors; Ferrous Compounds; Models, Chemical; Salicylates; Spectrophotometry

1981
Gentisic acid, an aspirin metabolite, inhibits oxidation of low-density lipoprotein and the formation of cholesterol ester hydroperoxides in human plasma.
    European journal of pharmacology, 2005, Apr-25, Volume: 513, Issue:3

    Topics: Antioxidants; Aspirin; Azo Compounds; Cell Line; Chelating Agents; Cholesterol Esters; Dose-Response Relationship, Drug; Ferrous Compounds; Free Radical Scavengers; Gentisates; Humans; In Vitro Techniques; Lipid Peroxides; Lipoproteins, LDL; Nitriles; Oxidation-Reduction

2005